NCT04631380已完成不适用
A Double Blind, Controlled, Randomized, Prospective Study That Will Evaluate the Impact of Remote Intercession Prayer on the Clinical Evolution of Patients Diagnosed With COVID -19 in HCOR.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 200
- 试验地点
- 2
- 主要终点
- DEATH OR RECOVERY
研究概览
简要总结
PATIENTS WHO ARE ADMITTED TO HOSPITALIZATION IN HCOR AND WHO HAVE THE CONFIRMED DIAGNOSIS OF CORONA VIRUS, WILL BE ASKED TO CONSENT TO PARTICIPATE IN THIS STUDY THAT INTENDS TO STUDY THE EFFECTIVENESS OF THE REMOTE INTERCESSION PRAYER IN COMBATING THIS DISEASE.
详细描述
PATIENTS WHO AGREE TO PARTICIPATE IN THE STUDY WILL BE SEPARATED INTO 2 GROUPS, THE INTERVENTION GROUP AND THE CONTROL GROUP.
THE IDENTITY OF THE PATIENTS WILL BE KEPT IN SECRET AND ONLY THEIR INITIALS WILL BE LISTED.
THE INTERVENTION GROUP WILL RECEIVE DAILY PRAYERS AND THE EVOLUTIONARY CLINICAL RESULTS OF THE TWO GROUPS WILL BE PURCHASED.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- Single (Participant)
盲法说明
RAMDOMIZED DOBLE-BLINDING
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients hospitalized in comun hospital rooms and intensive care units with confirmed COVID-19.
排除标准
- •Patients admitted to the HCor emergency room, diagnosed with COVID-19 infection, however, without indication for hospitalization
- •Patients admitted to the HCor emergency room, diagnosed with COVID-19 infection, however, without indication for hospitalization.
- •Patients 18 years of age or older
- •Patients with indication of palliative care and definition of terminality at hospital admission
- •Patients who voluntarily choose not to participate in the study at the time of the • presentation of the Informed Consent Form.
结局指标
主要结局
DEATH OR RECOVERY
时间窗: 60 DAYS
WE WILL EVALUATE DEATHS OR HOSPITAL DISCHARGE
次要结局
- TIME OF REMAINED INTUBATED(60 DAYS)
- LENGTH OF STAY IN ICU(60 DAYS)
- TIME OF STAY HOSPITALIZED(60 DAYS)
- NEED FOR MECHANICAL VENTILATION(60 DAYS)
- Occurrence of clinical complications.(60 DAYS)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Challenge study to determine the protective efficacy of a single oral dose of the attenuated 638 strain.Cholera diseaseHealthy VolunteersCholera /prevention & controlVibrio InfectionsGram-Negative Bacterial InfectionsBacterial InfectionsWaterborne DiseasesEnvironmental IllnessRPCEC00000072Finlay Institute27
已完成
不适用
Effectiveness of proteolytic enzymes in controlling the post operative sequelae of surgical third molar disimpactionsCTRI/2017/10/010076Dr Chalakuzhy Paul Mathai90
进行中（未招募）
不适用
A prospective, controlled, randomized, patient and evaluator blinded study to evaluate pain and further disabling complications in patients undergoing Lichtenstein technique for primary inguinal hernia repair by fixing the mesh with TISSUCOL/TISSEEL fibrin sealant versus sutures. - TIMELI 001nilateral, uncomplicated primary inguinal hernia repairClassification code 10022020EUCTR2005-002741-39-DKniversità di Milano, Dipartimento di Scienze Chirurgiche, Ospedale Maggiore Policlinico, Padiglione328
进行中（未招募）
1 期
A prospective, controlled, randomized, patient and evaluator blinded study to evaluate pain and further disabling complications in patients undergoing Lichtenstein technique for primary inguinal hernia repair by fixing the mesh with TISSUCOL/TISSEEL fibrin sealant versus sutures.EUCTR2005-002741-39-ESPr Giampiero CAMPANELLI - Ospedale Maggiore Policlinico, Padiglione Beretta Est328
进行中（未招募）
1 期
A prospective, controlled, randomized, patient and evaluator blinded study to evaluate pain and further disabling complications in patients undergoing Lichtenstein technique for primary inguinal hernia repair by fixing the mesh with fibrin sealant versus sutures. - TIMILI 001EUCTR2005-002741-39-GBProf. Giampiero CAMPANELLI328